| Primary |
| Upper Respiratory Tract Infection |
80.0% |
| Tooth Abscess |
20.0% |
|
| Chills |
12.5% |
| Dyspnoea |
12.5% |
| Idiopathic Thrombocytopenic Purpura |
12.5% |
| Pemphigoid |
12.5% |
| Rash |
12.5% |
| Rash Pustular |
12.5% |
| Toxic Epidermal Necrolysis |
12.5% |
| Vulvovaginal Discomfort |
12.5% |
|
| Secondary |
| Product Used For Unknown Indication |
24.4% |
| Prophylaxis |
18.7% |
| Drug Use For Unknown Indication |
12.4% |
| Tonsillitis |
7.9% |
| Acute Lymphocytic Leukaemia |
4.4% |
| Immunosuppression |
3.2% |
| Hypertension |
2.9% |
| Back Pain |
2.5% |
| Cholestasis |
2.5% |
| Insomnia |
2.5% |
| Anxiety |
2.2% |
| Hypothyroidism |
2.2% |
| Infection |
2.2% |
| Phlebitis |
2.2% |
| Haemolytic Uraemic Syndrome |
1.9% |
| Vitamin B12 Deficiency |
1.9% |
| Idiopathic Thrombocytopenic Purpura |
1.6% |
| Pneumonia |
1.6% |
| Chemotherapy |
1.3% |
| Convulsion |
1.3% |
|
| Thrombotic Microangiopathy |
10.9% |
| Toxic Optic Neuropathy |
9.1% |
| Intentional Overdose |
7.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.5% |
| Hyperchlorhydria |
5.5% |
| Nausea |
5.5% |
| Prostate Cancer |
5.5% |
| Pruritus |
5.5% |
| Vomiting |
5.5% |
| Acute Generalised Exanthematous Pustulosis |
3.6% |
| Hypokalaemia |
3.6% |
| Joint Range Of Motion Decreased |
3.6% |
| Muscular Weakness |
3.6% |
| Musculoskeletal Discomfort |
3.6% |
| Persistent Foetal Circulation |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Urticaria |
3.6% |
| Ventricular Hypertrophy |
3.6% |
| Vomiting Projectile |
3.6% |
|
| Concomitant |
| Multiple Myeloma |
20.6% |
| Product Used For Unknown Indication |
14.5% |
| Prophylaxis |
13.5% |
| Drug Use For Unknown Indication |
11.1% |
| Infection Prophylaxis |
7.1% |
| Pain |
6.1% |
| Antibiotic Prophylaxis |
3.7% |
| Bone Pain |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Acute Myeloid Leukaemia |
2.0% |
| Peripheral T-cell Lymphoma Unspecified |
2.0% |
| Epilepsy |
1.7% |
| Hypopituitarism |
1.7% |
| Antiviral Prophylaxis |
1.4% |
| Anxiety |
1.4% |
| Bone Marrow Transplant |
1.4% |
| Cytomegalovirus Infection |
1.4% |
| Folliculitis |
1.4% |
| Hiv Infection |
1.4% |
|
| Alanine Aminotransferase Increased |
10.2% |
| Cerebral Ischaemia |
8.2% |
| Chronic Lymphocytic Leukaemia |
8.2% |
| Lung Adenocarcinoma |
6.1% |
| Rash |
6.1% |
| Agranulocytosis |
4.1% |
| Arthralgia |
4.1% |
| Ascites |
4.1% |
| Basal Cell Carcinoma |
4.1% |
| Diarrhoea |
4.1% |
| Generalised Oedema |
4.1% |
| Hepatitis Cholestatic |
4.1% |
| Intravascular Haemolysis |
4.1% |
| Lung Disorder |
4.1% |
| Meningitis Meningococcal |
4.1% |
| Myocardial Infarction |
4.1% |
| Oesophagitis Ulcerative |
4.1% |
| Optic Neuritis |
4.1% |
| Paraesthesia |
4.1% |
| Rhabdomyolysis |
4.1% |
|
